[HTML][HTML] Pharmacological, neural, and psychological mechanisms underlying psychedelics: a critical review

M van Elk, DB Yaden - Neuroscience & Biobehavioral Reviews, 2022 - Elsevier
This paper provides a critical review of several possible mechanisms at different levels of
analysis underlying the effects and therapeutic potential of psychedelics. At the (1) …

Psychedelics and psychedelic-assisted psychotherapy

CM Reiff, EE Richman, CB Nemeroff… - American Journal of …, 2020 - Am Psychiatric Assoc
Objective: The authors provide an evidenced-based summary of the literature on the clinical
application of psychedelic drugs in psychiatric disorders. Methods: Searches of PubMed and …

The subjective effects of psychedelics are necessary for their enduring therapeutic effects

DB Yaden, RR Griffiths - ACS Pharmacology & Translational …, 2020 - ACS Publications
Classic psychedelics produce altered states of consciousness that individuals often interpret
as meaningful experiences. Across a number of human studies, when the participant-rated …

New and emerging approaches to treat psychiatric disorders

KW Scangos, MW State, AH Miller, JT Baker… - Nature medicine, 2023 - nature.com
Psychiatric disorders are highly prevalent, often devastating diseases that negatively impact
the lives of millions of people worldwide. Although their etiological and diagnostic …

Psychedelics in psychiatry: neuroplastic, immunomodulatory, and neurotransmitter mechanisms

A Inserra, D De Gregorio, G Gobbi - Pharmacological Reviews, 2021 - ASPET
Mounting evidence suggests safety and efficacy of psychedelic compounds as potential
novel therapeutics in psychiatry. Ketamine has been approved by the Food and Drug …

Awe as a pathway to mental and physical health

M Monroy, D Keltner - Perspectives on psychological science, 2023 - journals.sagepub.com
How do experiences in nature or in spiritual contemplation or in being moved by music or
with psychedelics promote mental and physical health? Our proposal in this article is awe …

Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review

N Schimmers, JJ Breeksema, SY Smith-Apeldoorn… - …, 2022 - Springer
Background Terminally ill patients may experience existential distress, depression, or
anxiety, limiting quality of life in the final stage. Existing psychotherapeutic or …

[HTML][HTML] LSD alters dynamic integration and segregation in the human brain

AI Luppi, RL Carhart-Harris, L Roseman, I Pappas… - NeuroImage, 2021 - Elsevier
Investigating changes in brain function induced by mind-altering substances such as LSD is
a powerful method for interrogating and understanding how mind interfaces with brain, by …

Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants

NL Galvão-Coelho, W Marx, M Gonzalez, J Sinclair… - …, 2021 - Springer
Rationale Major depressive disorder is one of the leading global causes of disability, for
which the classic serotonergic psychedelics have recently reemerged as a potential …

Ethical and legal issues in psychedelic harm reduction and integration therapy

B Pilecki, JB Luoma, GJ Bathje, J Rhea… - Harm Reduction …, 2021 - Springer
Psychedelic-assisted therapy may represent an upcoming paradigm shift in the treatment of
mental health problems as recent clinical trials have demonstrated strong evidence of their …